PERCIST Evaluation of Trastuzumab Deruxtecan in the Treatment of HER2 Low Breast Cancer
Clinical trial NCT07130344 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07130344
- Sponsor
- Centre Paul Strauss
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2028-12-01
- Enrollment
- 262
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.